Randomized Controlled Trial (RCT) of Open Debridement Versus Tenex

NCT ID: NCT05757739

Last Updated: 2025-01-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

90 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-02-09

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Lateral epicondylitis (Tennis Elbow) can cause pain and keep individuals from completing their daily activities and require them to miss work. There are currently different treatment options to address tennis elbow. However surgeons do not know if one is better than the other. This study will compare two treatment options for tennis elbow. Participants will either be treated by Ultrasound-guided Percutaneous Tenotomy Technique or Open Surgical Debridement. Traditional open surgical debridement is a surgical procedure that requires the surgeon to make an incision to remove the damaged tissue. This procedure is done under anesthesia in a surgery center. In the Tenex procedure, the surgeon inserts a special needle into the damaged portion of the tendon under ultrasound guidance. Ultrasonic energy vibrates the damaged tissue and it can be suctioned out. This procedure is done with local anesthesia in surgeon's office.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

During the initial screening visit, the physician will obtain your medical history and perform a physical exam. If you pass the screening, you will be randomized into either Ultrasound-guided Percutaneous Tenotomy Technique or Open Surgical Debridement. It will be a 50% chance. It will be compared to flipping a coin.

Once you have been placed in your treatment group, your treatment will be scheduled. You will then undergo your procedure and provided referral for physical therapy. You will also have follow up appointments with your physician to monitor your progress at 3 week(visit 3), 5 weeks (visit 4), 3 months (visit 5) 6 month (visit 6), and 12 month (visit 7) time points. You will also be requested to complete two patient questionnaires about your progress at visits 3-7.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Orthopedic Devices Associated With Misadventures

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Tenex

In the Tenex procedure, the surgeon inserts a special needle into the damaged portion of the tendon under ultrasound guidance. Ultrasonic energy vibrates the damaged tissue and it can be suctioned out. This procedure is done with local anesthesia in surgeon's office.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Individuals 18-70 years of age
* Clinically documented chronic lateral epicondylitis with a minimum of 6 months of persistent elbow pain that impedes daily activities.
* Failed alternative treatment for \> 3 months.

Exclusion Criteria

* Surgical procedure on affected extremity within last six months.
* Dermatological disorder in affected area
* Currently pregnant, confirmed via pregnancy test.
* Blood disorders, autoimmune disorders, disorders requiring immunosuppression, cancer, malignancies, an ongoing infectious disease, or sickle cell or other blood disorders.
* Failed prior surgical procedure on the affected joint.
* No prior effort to treat (stretching, rest, medication) or implementation of external protocol in an effort to improve condition (physical therapy, massage treatment, rehabilitation techniques).
Minimum Eligible Age

19 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Dr. Sean Mcmillan

UNKNOWN

Sponsor Role collaborator

Dr. Thomas Plut

UNKNOWN

Sponsor Role collaborator

Dr. Christopher Chung

UNKNOWN

Sponsor Role collaborator

Dr. Raymond Ragland

UNKNOWN

Sponsor Role collaborator

Dr. Nathan Bodin

UNKNOWN

Sponsor Role collaborator

Virtua Health, Inc.

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Virtua Health Inc

Burlington, New Jersey, United States

Site Status RECRUITING

Virtua Health and Wellness

Cherry Hill, New Jersey, United States

Site Status RECRUITING

Virtua Cadiac Testing Center

Moorestown, New Jersey, United States

Site Status RECRUITING

Virtua Hand Surgery

Riverside Park, New Jersey, United States

Site Status RECRUITING

Summit Surgical Center LLC

Voorhees Township, New Jersey, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Donna Hoopes

Role: CONTACT

856-355-1206

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Donna Hoopes

Role: primary

856-355-1206

Donna Hoopes

Role: primary

856-355-1206

Donna Hoopes

Role: primary

856-355-1206

Donna Hoopes

Role: primary

856-355-1206

Donna Hoopes

Role: primary

856-355-1206

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

G23004

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.